No Data
Telomir Pharmaceuticals Reaches US$198m Market Cap Benefiting Insider Stock Buying
Telomir Pharmaceuticals Insider Ups Holding During Year
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
No Data
No Data
